T2 Biosystems (TTOO) Form 4 T2 Biosystems / Thomas J. Lowery ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Lowery Thomas J.

(Last) (First) (Middle)

101 HARTWELL AVENUE

(Street)

LEXINGTON MA 02421

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
T2 Biosystems, Inc. [ TTOO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chief Scientific Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/18/2018

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/18/2018		M		14,647	A	$1.16	57,873	D
Common Stock	09/18/2018		M		18,588	A	$1.31	76,461	D
Common Stock	09/18/2018		M		29,411	A	$1.96	105,872	D
Common Stock	09/18/2018		M		36,235	A	$2.45	142,107	D
Common Stock	09/18/2018		M		1,361	A	$2.25	143,468	D
Common Stock	09/18/2018		S(1)		14,647	D	$6.14(2)	128,821	D
Common Stock	09/18/2018		S(1)		85,595	D	$6.17(3)	43,226	D
Common Stock	09/19/2018		M		10,403	A	$2.25	53,629	D
Common Stock	09/19/2018		M		27,499	A	$3.22	81,128	D
Common Stock	09/19/2018		S(1)		37,902	D	$6.2(4)	43,226	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$1.16	09/18/2018		M			14,647	02/27/2013	02/27/2019	Common Stock	14,647	$0.00	0	D
Stock Option (Right to Buy)	$1.31	09/18/2018		M			18,588	02/05/2014	02/05/2020	Common Stock	18,588	$0.00	0	D
(Stock Option (Right to Buy)	$1.96	09/18/2018		M			29,411	04/15/2015	04/15/2021	Common Stock	29,411	$0.00	0	D
Stock Option (Right to Buy)	$2.45	09/18/2018		M			36,235	01/17/2016	01/17/2022	Common Stock	36,235	$0.00	0	D
Stock Option (Right to Buy)	$2.25	09/18/2018		M			1,361	01/23/2017	01/23/2023	Common Stock	1,361	$0.00	10,403	D
Stock Option (Right to Buy)	$2.25	09/19/2018		M			10,403	01/23/2017	01/23/2023	Common Stock	10,403	$0.00	0	D
Stock Option (Right to Buy)	$3.22	09/19/2018		M			27,499	09/25/2017	09/25/2023	Common Stock	27,499	$0.00	31,603	D

Explanation of Responses:

1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2018.

2. The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $6.05 to $6.27. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $6.05 to $6.30. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $6.05 to $6.30. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ John Sprague, Attorney-in-fact	09/20/2018
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.